Tennessean, August 4, 2010

Vanderbilt-Ingram Cancer Center has launched the Personalized Cancer Medicine Program, a new initiative that is drilling down to the genetic level of patients to help tailor individualized treatments that would never have been possible in the past Vanderbilt is on the cutting edge with a handful of other institutions across the country using the new technique. Doctors are examining DNA of patients with lung cancer and melanoma tumors to identify what genetic mutation is causing the cancers to grow. A treatment that works for one patient might not work for another, so doctors hope to use information from the test to modify therapies for each patient. The program is the first of its kind in the Southeast and among only a handful across the country.



Facebook icon
LinkedIn icon
Twitter icon